Journal of Immunotherapy and Precision Oncology (JIPO)
Journal of Immunotherapy and Precision Oncology (JIPO) is a peer-reviewed, open-access journal that is published quarterly by Allen Press. JIPO aims to publish high-quality manuscripts that appeal to a broad readership of healthcare professionals and scientists, especially those with an interest in oncology and immunology. The scope of JIPO includes innovative original research articles related to translational science and clinical medicine, review articles, editorials, case reports, letters, guidelines, and more.
For more information and to submit an article, visit jipoonline.org.
pharmaphorum uses content to connect the pharmaceutical industry and other innovators to advance healthcare, leveraging its own global publications and delivering direct content marketing, medical and communications services to clients in the healthcare sector. pharmaphorum.com, and its associated digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate.
For more information and to submit an article, visit www.pharmaphorum.com
PharmaVOICE magazine reaches more than 46,000 BPA qualified subscribers and 60,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.
For more information and to submit an article, visit www.pharmavoice.com